IKang Guobin marks record overseas investment

IKang Guobin Healthcare Group, one of China's biggest healthcare companies, received a $100 million investment from Goldman Sachs Group and Government of Singapore Investment Corp.

The investment deal, which was officially signed on April 12, marked a new record high of foreign investment into the Chinese healthcare industry.

Zhang Ligang, chairman of iKang Guobin, said the group would witness a great expansion in the next eight years, in terms of both scale and the number of the clients.

He said that the group will serve about tens of millions clients every year by 2020.

By the end of March, iKang Guobin Healthcare Group has built 40 physical check centers in 12 cities nationwide. More than 500 medical centers and hospitals are cooperating with the group to provide a full range of healthcare service, including cancer screening and private healthcare service.

Thanks to the medical reform policies released by China's central government in 2012, private-owned medical institutions are expected to share 20 percent of the country’s whole medical service market by 2015.